![Longeveron Inc. logo](/logos/LGVN.webp)
Longeveron Inc.
NASDAQ:LGVN
Overview | Financials
Company Name | Longeveron Inc. |
Symbol | LGVN |
Currency | USD |
Price | 1.97 |
Market Cap | 28,288,172 |
Dividend Yield | 0% |
52-week-range | 0.771 - 26.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Mohamed Wa'el Ahmed Hashad |
Website | https://www.longeveron.com |
An error occurred while fetching data.
About Longeveron Inc.
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD